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contribute to allergic responses (3) . ILCs represent subsets of lymphocytes that express distinct patterns of cytokines and, similar to T and B cells, arise from a common lymphoid progenitor (CLP) cell (4) . Given that natural killer (NK) cells, the prototypical member of the ILC family (4), express Fc-receptors, their activity depends on the composition of the individual antibody repertoire (5, 6) , but is also tightly balanced by activating and inhibitory receptors (7) . NK cell inhibitory receptors are specific for MHC class I, whereas others recognize non-MHC protein or glycan ligands (7, 8) . Furthermore, Massi et al. reported that endogenous cannabinoids inhibit NK cell activity by engagement of the G protein-coupled cannabinoid receptors CB1 and CB2 (9) . In contrast to NK cells, which have been classified as group 1 ILC, group 2 innate lymphoid cells (ILC2) are characterized by the production of T helper 2 (T H 2) cell-associated cytokines (3), and increasing evidence demonstrates their contribution to allergic disorders, including asthma (reviewed in (4) 
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This article is protected by copyright. All rights reserved. Early studies in the seventies revealed a beneficial effect of inhaled or orally taken cannabinoids by dilating bronchial smooth muscles (12, 13) . Since then, both anti-and proinflammatory effects of endocannabinoids have been reported, which has been attributed, in part, to bioactive metabolites and signalling by additional receptors, aside from CB1 and CB2, which are both expressed on human leukocytes (14) . Several studies using mice lacking the CB2 receptor have shown exacerbated inflammation in different disease models (15) . In contrast, Ferrini et al. (11) demonstrate in the HDM-induced asthma model using CB2 -/-mice that CB2 augments allergen responsiveness. Interestingly, an allergy promoting role of CB2 was also observed in an ear dermatitis model with CB2 -/-mice (16) , and by the use of the CB2 receptor agonist JWH-133 in a OVA-induced asthma model with C57BL6
mice showing a direct effect of CB2 on eosinophil responses (17) . This raises the question if
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the immunomodulatory role of CB2 may depend on the type of immune response (e.g.
allergic versus non-allergic). Further studies will be required to address this question or to exclude potential confounding variables, e.g. related to the disease model or mouse strain used (18, 19) . In this regard, abnormalities in the development of several lymphocyte subsets have been reported in CB2 -/-mice (20) .
The finding by Ferrini et al. (11) 
